Page 28 - 南京医科大学学报自然科学版
P. 28
第43卷第5期
·610 · 南 京 医 科 大 学 学 报 2023年5月
重要领域,本研究证实,mTOR信号通路可调控与卵 [7] HUA H,KONG Q,ZHANG H,et al. Targeting mTOR for
巢癌细胞共培养的CD4 Treg糖代谢,在促进免疫抑 cancer therapy[J]. J Hematol Oncol,2019,12(1):71
+
制微环境从而导致卵巢癌免疫逃逸的过程中发挥 [8] CLUXTON D,PETRASCA A,MORAN B,et al. Differen⁃
至关重要的作用。因此,在肿瘤微环境中,针对这 tial regulation of human Treg and Th17 cells by fatty acid
synthesis and glycolysis[J]. Front Immunol,2019,10:115
一通路进行 Treg 细胞能量代谢的再编程可能是一
[9] 徐 睿,王 芳. 调节性 T 细胞糖代谢的研究进展[J].
种新的肿瘤治疗策略,有望为卵巢癌的免疫治疗提
细胞与分子免疫学杂志,2021,37(4):378-382
供新的靶点。有研究认为,mTOR 的活性被认为是 [10] 吴 茗,徐 睿,刘书娜,等. 卵巢癌细胞生长环境中
维持其抑制能力的必要条件 [18] ,目前的研究暂不足 CD4 Treg 细胞和 CD4 Teff 细胞的糖代谢特征初探[J].
+
+
以说明 mTOR 信号通路是否与卵巢癌微环境中 南京医科大学学报(自然科学版),2021,41(7):999-
CD4 Treg的抑制功能有关,而mTOR信号通路是否 1005
+
通过调控 CD4 Treg 糖代谢进而影响其免疫抑制功 [11] HAO E Y,WANG D H,CHEN Y F,et al. The relation⁃
+
能将是我们未来研究的重点。 ship between the mTOR signaling pathway and ovarian ag⁃
ing in peak⁃phase and late⁃phase laying hens[J]. Poult
[参考文献]
Sci,2021,100(1):334-347
[1] COMPTON S L E,GRIECO J P,GOLLAMUDI B,et al. [12] HUANG S. mTOR signaling in metabolism and cancer[J].
Metabolic reprogramming of ovarian cancer spheroids dur⁃ Cells,2020,9(10):2278
ing adhesion[J]. Cancers(Basel),2022,14(6):1399 [13] MOSSMANN D,PARK S,HALL M N. mTOR signalling
[2] MOUFARRIJ S,DANDAPANI M,ARTHOFER E,et al. and cellular metabolism are mutual determinants in can⁃
Epigenetic therapy for ovarian cancer:promise and prog⁃ cer[J]. Nat Rev Cancer,2018,18(12):744-757
ress[J]. Clin Epigenetics,2019,11(1):7 [14] SALMOND R J. mTOR regulation of glycolytic metabo⁃
[3] LI L,LIU X,SANDERS K L,et al. TLR8⁃mediated meta⁃ lism in T cells[J]. Front Cell Dev Biol,2018,6:122
bolic control of human treg function:a mechanistic target [15] VALLION R,DIVOUX J,GLAUZY S,et al. Regulatory T
for cancer immunotherapy[J]. Cell Metab,2019,29(1): cell stability and migration are dependent on mTOR[J]. J
103-123 Immunol,2020,205(7):1799-1809
[4] LI T E,WANG S,SHEN X T,et al. PKM2 drives hepato⁃ [16] ALMEIDA L,LOCHNER M,BEROD L,et al. Metabolic
cellular carcinoma progression by inducing immunosup⁃ pathways in T cell activation and lineage differentiation
pressive microenvironment[J]. Front Immunol,2020,11: [J]. Semin Immunol,2016,28(5):514-524
589997 [17] WAICKMAN A T,POWELL J D. mTOR,metabolism,and
[5] SHANG W,XU R,XU T,et al. Ovarian cancer cells pro⁃ the regulation of T ⁃ cell differentiation and function[J].
mote glycolysis metabolism and TLR8⁃mediated metabol⁃ Immunol Rev,2012,249(1):43-58
ic control of human CD4 T cells[J]. Front Oncol,2020, [18] SHI H,CHAPMAN N M,WEN J,et al. Amino acids li⁃
+
10:570899 cense kinase mTORC1 activity and treg cell function via
[6] XU R,WU M,LIU S,et al. Glucose metabolism character⁃ small G proteins rag and rheb[J]. Immunity,2019,51
+
istics and TLR8⁃mediated metabolic control of CD4 Treg (6):1012-1027
cells in ovarian cancer cells microenvironment[J]. Cell [收稿日期] 2022-12-13
Death Dis,2021,12(1):22 (本文编辑:唐 震)